Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-12-191684
Filing Date
2012-04-27
Accepted
2012-04-27 17:18:46
Documents
4
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 ON FORM 10-K d341087d10ka.htm 10-K/A 531045
2 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 d341087dex311.htm EX-31.1 9978
3 CERTIFICATION OF THE CHIEF ACCOUNTING OFFICER PURSUANT TO SECTION 302 d341087dex312.htm EX-31.2 9974
4 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER AND CHIEF ACCOUNTING OFFICER d341087dex320.htm EX-32.0 5993
  Complete submission text file 0001193125-12-191684.txt   558235
Mailing Address 12117 BEE CAVES ROAD BUILDING TWO SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING TWO SUITE 100 AUSTIN TX 78738 512-519-0400
VERMILLION, INC. (Filer) CIK: 0000926617 (see all company filings)

EIN.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-34810 | Film No.: 12791046
SIC: 2835 In Vitro & In Vivo Diagnostic Substances